Atlas Trials

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

Clinical trial NCT06183307 · RECRUITING

Trial details

NCT number
NCT06183307
Sponsor
Universidade Federal Fluminense
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Cardiovascular DiseasesDyslipidemiasInflammation
Start date
2024-08-03
Primary completion
2026-12-20
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.